Héroux-Devtek (TSE:HRX – Free Report) had its price objective upped by National Bankshares from C$23.00 to C$25.00 in a research report sent to investors on Tuesday morning, BayStreet.CA reports. National Bankshares currently has an outperform rating on the stock.
Several other brokerages have also commented on HRX. TD Securities upgraded Héroux-Devtek from a hold rating to a buy rating and raised their price target for the company from C$19.00 to C$23.00 in a research note on Thursday, February 8th. Scotiabank raised their price target on Héroux-Devtek from C$21.00 to C$22.50 and gave the company an outperform rating in a research note on Wednesday, April 10th. Finally, Desjardins raised their price target on Héroux-Devtek from C$21.00 to C$26.00 and gave the company a buy rating in a research note on Thursday, February 8th.
Check Out Our Latest Stock Report on HRX
Héroux-Devtek Stock Performance
Héroux-Devtek (TSE:HRX – Get Free Report) last released its earnings results on Wednesday, February 7th. The company reported C$0.27 earnings per share for the quarter, topping analysts’ consensus estimates of C$0.17 by C$0.10. Héroux-Devtek had a return on equity of 6.05% and a net margin of 3.97%. The business had revenue of C$163.52 million for the quarter, compared to analyst estimates of C$148.55 million. Analysts predict that Héroux-Devtek will post 1.0745934 earnings per share for the current year.
About Héroux-Devtek
Héroux-Devtek Inc engages in the design, development, manufacture, finishing, assembling, and repair and overhaul of aircraft landing gears, hydraulic and electromechanical flight control actuators, custom ball screws, and fracture-critical components. The company serves commercial and defence sectors of the aerospace market.
Further Reading
- Five stocks we like better than Héroux-Devtek
- Investing In Automotive Stocks
- Silicon Motion Proves That AI in Motion Stays in Motion
- 3 REITs to Buy and Hold for the Long Term
- Undervalued UnitedHealth Group Won’t Be For Long
- Which Wall Street Analysts are the Most Accurate?
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Héroux-Devtek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Héroux-Devtek and related companies with MarketBeat.com's FREE daily email newsletter.